Combined assessment using MSUS semiquantitative scores and inflammatory biomarkers may improve diagnostic accuracy and ...

HealthDay News — Higher levels of aggression in early adolescence predict more advanced biological aging by age 30 years, according to a study published online March 5 in Health Psychology.

The CDC is urging people to make sure their vaccinations are up to date, as the polio virus has been detected in several parts of the world during the past year.

The annual meeting of the AAOS highlighted recent advances in the diagnosis and management of musculoskeletal conditions.

Higher SUA levels were associated with a lower risk for osteoporosis, with sex, race, diabetes status, and serum cholesterol ...

Bimekizumab was superior to risankizumab at 16 weeks for improving PsA symptoms in a head-to-head clinical trial.

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Obinutuzumab was superior to placebo for systemic lupus erythematosus in a phase 3 trial, significantly improving SRI-4 response rates.

The FDA accepted a New Drug Application with Priority Review for brepocitinib, an oral TYK2/JAK1 inhibitor, for the treatment of dermatomyositis.

Testosterone replacement therapy before total knee arthroplasty was linked to higher risks for systemic and periprosthetic complications.

GLP-1 receptor agonist use was linked to a significantly higher risk for osteoporosis, gout, and osteomalacia over 5 years.